Shanghai Henlius Biotech Management Reshuffle
Shanghai Henlius Biotech announces key leadership changes, appointing new secretarial roles to ensure regulatory compliance.
- Latest
- Trending
Shanghai Henlius Biotech announces key leadership changes, appointing new secretarial roles to ensure regulatory compliance.
Ethereum staking reaches 34M ETH with 1.06M validators, signaling robust growth in network's PoS model.
Ethereum reserves hit lows; ETH struggles to maintain $2,800. Bearish signals emerge amid investor interest.
Io.net names Tory Green as CEO, leading a new team to expand its GPU cloud services in the competitive market.
PDD Holdings misses revenue estimates; warns of growth pressures, sending stock plummeting over 25% amid investor concerns.
Investors focus on economic data as interest rate cuts near, assessing the likelihood of a soft landing for U.S. stocks.
M&A transactions are prime targets for hackers due to digital presence and financial gains.
Blackrock's ETH ETF hits $1B in net flows in 21 days, outpacing competitors like Grayscale facing $2.5B in outflows.
OpenAI criticizes California's AI bill, fearing it may hinder innovation and competitiveness, urging for federal regulation.
Toll Brothers surpasses Q3 expectations with record revenues. Raises full-year outlook amid strong market demand.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.